Clinical verification of (18)F-DCFPyL PET-detected lesions in patients with biochemically recurrent prostate cancer

PURPOSE: Radiolabeled Prostate-Specific Membrane Antigen (PSMA) PET/CT is the current standard-of-care for lesion detection in patients with biochemically recurrent (BCR) prostate cancer (PCa). However, rigorous verification of detected lesions is not always performed in routine clinical practice. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Meijer, Dennie, Jansen, Bernard H. E., Wondergem, Maurits, Bodar, Yves J. L., Srbljin, Sandra, Vellekoop, Annelies E., Keizer, Bram, van der Zant, Friso M., Hoekstra, Otto S., Nieuwenhuijzen, Jakko A., Dahele, Max, Vis, André N., Oprea-Lager, Daniela E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7537873/
https://www.ncbi.nlm.nih.gov/pubmed/33021980
http://dx.doi.org/10.1371/journal.pone.0239414

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7537873/
https://www.ncbi.nlm.nih.gov/pubmed/33021980
http://dx.doi.org/10.1371/journal.pone.0239414

Ejemplares similares